Company: NUVI
Filing Date: 2025-03-04
Form Type: 1-SA
Source: 0001410708-25-000001
Chunk: 12

Company: Emo Capital Corp.
Filing Date: 2025-03-04
Form: 1-SA
Chunk 12
---
       - |     |                  | 1,000 |     |                         | 1 |     |            |       999 |     |             | -          |   |     |        |      1,000 |   |
| Shares issued for paying loans          |     |               | 220,000,000 |     |                      | 220,000 |     |                  |     - |     |                         | - |     |            |   880,000 |     |             | -          |   |     |        |  1,100,000 |   |
| Net loss                                |     |               |           - |     |                      |       - |     |                  |     - |     |                         | - |     |            |         - |     |             | (1,103,588 | ) |     |        | (1,103,588 | ) |
| Balance July 31, 2023                   |     |               | 315,500,000 |     | $                    | 285,500 |     |                  |  1000 |     | $                       | 1 |     | $          | 1,507,999 |     | $           | (1,857,784 | ) |     |        |    (64,284 | ) |

<div align='center'>The accompanying notes are an integral part of these financial statements.</div>

| F-3 |

Table of contents

<div align='center'>EMO CAPITAL, CORP.

STATEMENTS OF CASH FLOWS

(unaudited)</div>

|                                                                               |     | For the date ended 
 January 31, 2025   |        |   |     | July 31, 2024 |          |   |
|:------------------------------------------------------------------------------|:----|:-------------------|-------:|:--|:----|:--------------|---------:|:--|
| OPERATING ACTIVITIES:                                                         |     |                    |        |   |     |               |          |   |
| Net loss                                                                      |     | $                  | (1,641 | ) |     | $             | (596,844 | ) |
| Adjustments to reconcile net loss to net cash (used in) operating activities: |     |                    |        |   |     |               |          |   |
| Shares issued for joint venture                                               |     |                    |      - |   |     |               |  294,000 |